These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 13671490)

  • 1. [Azauracil in the treatment of lymphogranuloma].
    KONIG J
    Cas Lek Cesk; 1959 Jul; 98(28):875-6. PubMed ID: 13671490
    [No Abstract]   [Full Text] [Related]  

  • 2. [Our first clinical experiences with azauracil].
    MODR Z; SMAHEL O; SVEHLA C
    Cas Lek Cesk; 1959 Jul; 98(28):873-4. PubMed ID: 13671489
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the treatment of lymphogranuloma].
    Hammer B
    Wien Med Wochenschr; 1966 Jun; 116(25):562-5. PubMed ID: 5995246
    [No Abstract]   [Full Text] [Related]  

  • 4. Potentiation of the antitumorous action of 6-azauracil by procaine and excretion of 6-azauracil from the body.
    KEILOVA H; SORM F
    Neoplasma; 1957; 4(3):204-7. PubMed ID: 13504364
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the carcinostatic activity in mice of 6-azauracil riboside (azauridine), in comparison with that of 6-azauracil.
    JAFFE JJ; HANDSCHUMACHER RE; WELCH AD
    Yale J Biol Med; 1957 Dec; 30(3):168-75. PubMed ID: 13507398
    [No Abstract]   [Full Text] [Related]  

  • 6. [Histopathological data on Bayer E-39 in malignant lymphogranuloma].
    BRAMEZZA M; COZZI PA
    Friuli Med; 1957; 12(4):548-56. PubMed ID: 13490632
    [No Abstract]   [Full Text] [Related]  

  • 7. [Azauracil in the treatment of lymphogranuma].
    KONIG J
    Cas Lek Cesk; 1959 Jul; 98():875-6. PubMed ID: 14410853
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the pharmacology of 6-azauracil.
    WELCH AD; HANDSCHUMACHER RE; JAFFE JJ
    J Pharmacol Exp Ther; 1960 Jul; 129():262-70. PubMed ID: 13843819
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with 6-azauracil.
    CERNY V; SANDOR L; UJHAZY V; WINKLER A
    Neoplasma; 1959; 6():175-8. PubMed ID: 13808875
    [No Abstract]   [Full Text] [Related]  

  • 10. The biosynthesis of 6-azauracil riboside by Escherichia coli growing in the presence of 6-azauracil.
    SKODA J; HESS VF; SORM F
    Experientia; 1957 Apr; 13(4):150-1. PubMed ID: 13447904
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of 6-azauracil on the metabolism of Bacillus cereus.
    SELLS BH
    Biochem Pharmacol; 1959 Nov; 2():255-63. PubMed ID: 14444759
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of Hodgkin disease and non-Hodgkin lymphomas].
    Sréter L
    Orv Hetil; 2003 Dec; 144(49):2429-31. PubMed ID: 14725211
    [No Abstract]   [Full Text] [Related]  

  • 13. [The problem of treatment of Hodgkin's lymphogranulomatosis].
    MAURER HJ
    Arztl Wochensch; 1959 Jan; 14(3):49-52. PubMed ID: 13626697
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the mechanism of action of 6-azauracil.
    TAKAGI Y; OTSUJI N
    Biochim Biophys Acta; 1958 Jul; 29(1):227-8. PubMed ID: 13560479
    [No Abstract]   [Full Text] [Related]  

  • 15. [Respiratory function in malignant lymphogranuloma with mediastinal localization before and after roentgenotherapy or cytostatic therapy. (Spirographical study)].
    CORBETTA F; FERRERO E; FRACCHIA P; TIMOSSI G
    Riv Patol Clin; 1960 Dec; 15():925-34. PubMed ID: 13695441
    [No Abstract]   [Full Text] [Related]  

  • 16. [Advances in the treatment of morbus Hodgkin (author's transl)].
    Obrecht JP; Weber W
    Schweiz Rundsch Med Prax; 1981 Jun; 70(26):1174-84. PubMed ID: 7267603
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of orotidylic acid decarboxylase, a primary site of carcinostasis by 6-azauracil.
    HANDSCHUMACHER RE; PASTERNAK CA
    Biochim Biophys Acta; 1958 Nov; 30(2):451-2. PubMed ID: 13607480
    [No Abstract]   [Full Text] [Related]  

  • 18. Accumulation of nucleic acid metabolites in Escherichia coli exposed to the action of 6-azauracil.
    SKODA J; SORM F
    Biochim Biophys Acta; 1958 Jun; 28(3):659-60. PubMed ID: 13560432
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphomas.
    Santoro A; Castagna L; Magagnoli M
    Cancer Chemother Biol Response Modif; 2003; 21():399-428. PubMed ID: 15338757
    [No Abstract]   [Full Text] [Related]  

  • 20. [Favorable development of Hodgkin's disease treated with E 39].
    ZAIMI A; BEN ABDALLAH T; LEGROS N
    Tunis Med; 1958 Jun; 36(6):331 passim. PubMed ID: 13592972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.